ANI PHARMACEUTICALS INC — Director's Dealing 2014

Mar 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2014-03-18

Reporting Person: MARSHBANKS TRACY (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-18	Common Stock	S	14851	$33.8264	Disposed	537643	Indirect
2014-03-18	Common Stock	S	6029	$33.8264	Disposed	218273	Indirect
2014-03-18	Common Stock	S	232	$33.8264	Disposed	8397	Indirect
2014-03-19	Common Stock	S	2986	$32.9781	Disposed	534657	Indirect
2014-03-19	Common Stock	S	1213	$32.9781	Disposed	217060	Indirect
2014-03-19	Common Stock	S	47	$32.9781	Disposed	8350	Indirect

Footnotes

F1: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).

F2: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).

F3: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).